Company intelligence / Profile preview

Doc Ackerman's Pet Products

Oxnard, California, United States

Ownership: Private
Development stage: Other

Overview

Doc Ackerman's Pet Products sells herbal remedies, including the Epilepsy & Seizure Formula and Nerve & Anxiety Formula, marketed for pets but not FDA approved; the company received a warning letter from the FDA in November 2024 for marketing unapproved new animal drugs claiming to treat and control seizures in dogs and cats[9][12][7][2][10][13].

Therapeutic areas: NeurologyPsychiatry
Modalities: Herbal supplementNon-pharmacological therapy
Industry: Veterinary

Beyond the preview

Go deeper on Doc Ackerman's Pet Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Doc Ackerman's Pet Products.

Explore the full profile